Geodon (ziprasidone) is an atypical antipsychotic medication primarily used to treat schizophrenia and bipolar disorder in adults[1][2][3][4][5].
- Schizophrenia: Geodon is indicated for the treatment of schizophrenia in adults, helping manage symptoms such as hallucinations, delusions, and thought disorders[1][2][3][4][5][6][7].
- Bipolar I Disorder:
- As monotherapy, Geodon is used for the acute treatment of manic or mixed episodes associated with bipolar I disorder[1][2][3][4][5].
- As an adjunct to lithium or valproate, it is used for the maintenance treatment of bipolar I disorder to help prevent recurrence of mood episodes[1][2][3][4][5].
- Acute Agitation in Schizophrenia: The intramuscular (IM) formulation of Geodon is indicated for the rapid management of acute agitation in adult patients with schizophrenia who require urgent behavioral control[1][2][3][5].
- Off-label Uses: While not FDA-approved, Geodon may sometimes be prescribed off-label for conditions such as delusional parasitosis, hypomania in bipolar II disorder, and agitation or aggression due to other medical or substance-related causes[5].
Geodon works by balancing neurotransmitters in the brain, particularly serotonin and dopamine, to improve mood, thoughts, and behavior[6]. Prescribers should consider the risk of QT interval prolongation and heart rhythm disturbances associated with this medication[1][2][3]. Geodon is not approved for use in children or adolescents and is typically reserved for adults. Oral formulations are taken with food, and IM injections are administered by a clinician for acute psychiatric emergencies[2][3].
References
- [1] Geodon (Ziprasidone): Side Effects, Uses, Dosage, Interactions
- [2] Ziprasidone (Geodon) Indications: FDA-Approved Uses
- [3] geodon – accessdata.fda.gov
- [4] Information for patients taking GEODON or their caregivers – Pfizer
- [5] Ziprasidone – StatPearls – NCBI Bookshelf
- [6] Ziprasidone (Geodon) – Uses, Side Effects, and More – WebMD
- [7] Ziprasidone (Geodon) | National Alliance on Mental Illness (NAMI)
Leave a Reply